{"transactions":[{"id":1854140,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T22:14:19.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":35354,"price":4.95,"value":175002.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":117024,"source":{"system":"sec-edgar","filing":"0001376339-23-000040","document":"wk-form4_1686867247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000040/wk-form4_1686867247.xml","form_type":"4"}},{"id":2233939,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T22:32:20.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":44191,"price":3.96,"value":174996.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":81670,"source":{"system":"sec-edgar","filing":"0001376339-22-000091","document":"wf-form4_165515952512983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000091/wf-form4_165515952512983.xml","form_type":"4"}},{"id":2691053,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T18:26:25.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":17056,"price":10.26,"value":174994.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents annual restricted stock grant to non-employee directors.  Grant is exempt under Rule 16b-3.  The award vests upon the earlier of 12 months or the next annual meeting of shareholders."}],"balance_after":37479,"source":{"system":"sec-edgar","filing":"0001376339-21-000075","document":"wf-form4_162222636414395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633921000075/wf-form4_162222636414395.xml","form_type":"4"}},{"id":2735749,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T20:30:36.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":4084,"price":10.71,"value":43739.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Grant of restricted stock units which vest in full on the first anniversary date of the grant."}],"balance_after":20423,"source":{"system":"sec-edgar","filing":"0001376339-21-000034","document":"wf-form4_161972821997477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633921000034/wf-form4_161972821997477.xml","form_type":"4"}},{"id":2735748,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T20:30:36.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":16339,"price":10.71,"value":174990.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units which vest in equal parts over three years from the date of the grant."}],"balance_after":16339,"source":{"system":"sec-edgar","filing":"0001376339-21-000034","document":"wf-form4_161972821997477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633921000034/wf-form4_161972821997477.xml","form_type":"4"}},{"id":2737079,"issuer":{"id":124935,"kind":"organization","name":"CohBar, Inc.","symbol":"CWBR"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-04-28T16:07:11.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option shall vest over 48 successive equal installments (rounded down to the nearest whole share, except for the last vesting installment) beginning April 26, 2021."}],"balance_after":200000,"derivative":{"exercise_price":1.38,"expiration_date":"2031-04-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-21-023261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000121390021023261/ownership.xml","form_type":"4"}},{"id":3147221,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-05-15T18:39:52.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on May 14, 2021, the one year anniversary from the grant date, subject to Dr. Gardner's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":19.4,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001479290-20-000067","document":"wf-form4_158958237463980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929020000067/wf-form4_158958237463980.xml","form_type":"4"}},{"id":3147220,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T18:39:52.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on May 14, 2021, the one year anniversary from the grant date, subject to Dr. Gardner's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001479290-20-000067","document":"wf-form4_158958237463980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929020000067/wf-form4_158958237463980.xml","form_type":"4"}},{"id":3531505,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-05-10T21:05:06.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 9, 2020, subject to Dr. Gardner's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":9000,"derivative":{"exercise_price":12.82,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001479290-19-000058","document":"wf-form4_155753668980016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929019000058/wf-form4_155753668980016.xml","form_type":"4"}},{"id":3531504,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:05:06.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 9, 2020, subject to Dr. Gardner's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001479290-19-000058","document":"wf-form4_155753668980016.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929019000058/wf-form4_155753668980016.xml","form_type":"4"}},{"id":3662683,"issuer":{"id":124935,"kind":"organization","name":"CohBar, Inc.","symbol":"CWBR"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-02-12T11:49:42.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to option shall vest in 48 successive monthly installments beginning February 8, 2019."}],"balance_after":200000,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-009183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000120919119009183/doc4.xml","form_type":"4"}},{"id":3750190,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-28T19:52:05.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":12.5,"value":187500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-18-007065","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000156761918007065/doc1.xml","form_type":"4"}},{"id":3750189,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-28T19:52:05.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":12.5,"value":187500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-18-007065","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000156761918007065/doc1.xml","form_type":"4"}},{"id":3750188,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-28T19:52:05.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":12.5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.19,"expiration_date":"2025-12-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-18-007065","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000156761918007065/doc1.xml","form_type":"4"}},{"id":3750187,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-28T19:52:05.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":12000,"price":12.5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.79,"expiration_date":"2024-12-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001567619-18-007065","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000156761918007065/doc1.xml","form_type":"4"}},{"id":3750186,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-11-28T19:52:05.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":7920,"price":12.5,"value":99000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.141,"expiration_date":"2024-01-25","underlying":"Common Stock","underlying_shares":7920},"source":{"system":"sec-edgar","filing":"0001567619-18-007065","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000156761918007065/doc1.xml","form_type":"4"}},{"id":3750185,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-28T19:52:05.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":34203,"price":12.5,"value":427537.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-007065","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000156761918007065/doc1.xml","form_type":"4"}},{"id":3937014,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-05-11T20:28:28.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 10, 2019, subject to Dr. Gardner's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":6000,"derivative":{"exercise_price":29.15,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001479290-18-000079","document":"wf-form4_152608489454453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000079/wf-form4_152608489454453.xml","form_type":"4"}},{"id":3937013,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-11T20:28:28.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 10, 2019, subject to Dr. Gardner's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001479290-18-000079","document":"wf-form4_152608489454453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000079/wf-form4_152608489454453.xml","form_type":"4"}},{"id":3992406,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T20:35:42.000Z","date":"2018-03-16","kind":"exercise","acquired":true,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option is fully vested as of January 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":2.55,"expiration_date":"2020-07-20","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001479290-18-000054","document":"wf-form4_152124692840531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000054/wf-form4_152124692840531.xml","form_type":"4"}},{"id":3992405,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T20:35:42.000Z","date":"2018-03-16","kind":"exercise","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested as of January 1, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.55,"expiration_date":"2018-04-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001479290-18-000054","document":"wf-form4_152124692840531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000054/wf-form4_152124692840531.xml","form_type":"4"}},{"id":3992404,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T20:35:42.000Z","date":"2018-03-16","kind":"sale","acquired":false,"shares":5333,"price":31.5105,"value":168045.4965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Table 1, Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $31.50 to $31.55. Dr. Gardner undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001479290-18-000054","document":"wf-form4_152124692840531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000054/wf-form4_152124692840531.xml","form_type":"4"}},{"id":3992403,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T20:35:42.000Z","date":"2018-03-16","kind":"exercise","acquired":true,"shares":1333,"price":2.55,"value":3399.15,"ownership":{"direct":true},"balance_after":8333,"source":{"system":"sec-edgar","filing":"0001479290-18-000054","document":"wf-form4_152124692840531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000054/wf-form4_152124692840531.xml","form_type":"4"}},{"id":3992402,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T20:35:42.000Z","date":"2018-03-16","kind":"exercise","acquired":true,"shares":4000,"price":2.55,"value":10200.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001479290-18-000054","document":"wf-form4_152124692840531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929018000054/wf-form4_152124692840531.xml","form_type":"4"}},{"id":4141686,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-12-05T19:37:35.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12th of the total number of shares on January 1, 2018 and then 1/12th monthly thereafter."}],"balance_after":15000,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-045105","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000114036117045105/doc1.xml","form_type":"4"}},{"id":4228437,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-08-21T18:07:32.000Z","date":"2017-08-21","kind":"exercise","acquired":false,"shares":33064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.121,"expiration_date":"2017-11-08","underlying":"Common Stock","underlying_shares":33064},"source":{"system":"sec-edgar","filing":"0001140361-17-032873","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000114036117032873/doc1.xml","form_type":"4"}},{"id":4228436,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-21T18:07:32.000Z","date":"2017-08-21","kind":"exercise","acquired":true,"shares":33064,"price":2.121,"value":70128.744,"ownership":{"direct":true},"balance_after":34203,"source":{"system":"sec-edgar","filing":"0001140361-17-032873","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000114036117032873/doc1.xml","form_type":"4"}},{"id":4322699,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-12T19:49:32.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, May 11, 2018, subject to Dr. Gardner's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Compensation Policy."}],"balance_after":6000,"derivative":{"exercise_price":20.9,"expiration_date":"2027-05-10","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-032208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000120919117032208/doc4.xml","form_type":"4"}},{"id":4322698,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-12T19:49:32.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the one year anniversary, May 11, 2018, subject to Dr. Gardner's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-17-032208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000120919117032208/doc4.xml","form_type":"4"}},{"id":4511770,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":112275,"kind":"person","name":"GARDNER PHYLLIS","position":1,"cik":"0001238646","reported_name":"GARDNER PHYLLIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2016-12-27T18:39:25.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12th of the total number of shares on January 22, 2017 and then 1/12th monthly thereafter."}],"balance_after":15000,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-16-090847","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1238646/000114036116090847/doc1.xml","form_type":"4"}}]}